ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

This study is currently recruiting patients.

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry is to connect people with DM or FSHD with researchers studying these diseases.

Condition
Myotonic Dystrophy
Muscular Dystrophy, Facioscapulohumeral
Muscular Dystrophy

MedlinePlus related topics:  Degenerative Nerve Diseases;   Genetic Disorders;   Muscle Disorders;   Muscular Dystrophy
Genetics Home Reference related topics:  myotonic dystrophy

Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Prospective Study

Official Title: National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members

Further Study Details: 

Expected Total Enrollment:  9622

The National Registry of DM and FSHD Patients and Family Members was started to help people with DM and FSHD participate in research on their diseases, to help scientists accomplish research on DM or FSHD, and to encourage more research on these diseases.

People wishing to join this registry complete a consent form, sign an Authorization for Release of Medical Information, and fill out a multi-page Patient Information Form asking for information about their medical and educational/vocational histories and functional abilities. Medical records will be collected from potential participants' physicians. People meeting the diagnostic criteria for inclusion will be added to the registry and are then eligible for research studies that use the registry to recruit participants. There are no study visits associated with membership in the registry. Members of the registry will be contacted annually by mail to update the details of their last Patient Information Form.

Eligibility

Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria


Location and Contact Information

Colleen M. Donlin-Smith, MA      585-275-6372    Colleen_DonlinSmith@urmc.rochester.edu
Eileen Eastwood      585-275-6372    Eileen_Eastwood@urmc.rochester.edu

New York
      University of Rochester Medical Center, Department of Neurology, Rochester,  New York,  14642,  United States; Recruiting
Colleen M. Donlin-Smith, MA  585-275-6372    Colleen_DonlinSmith@urmc.rochester.edu 
Eileen Eastwood  585-275-6372    Eileen_Eastwood@urmc.rochester.edu 
Richard T. Moxley, III, MD,  Principal Investigator
Rabi Tawil, MD,  Sub-Investigator

Study chairs or principal investigators

Richard T. Moxley, III, MD,  Principal Investigator,  University of Rochester Medical Center, Department of Neurology   

More Information

Click here for more information about the National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members

Study ID Numbers:  NIAMS-104; NO1-AR-0-2250
Record last reviewed:  September 2004
Record first received:  April 29, 2004
ClinicalTrials.gov Identifier:  NCT00082108
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act